Japanese Phase I Trials List of articles

ELIQUENT Japan > Japanese Phase I Trials

2025.09.30

Holograms,of,capsule;,charts,and,dna,helix,on,scientific,backdrop.

Key Takeaways from the PMDA Symposium on Japanese Phase I Trials Before MRCT Participation

Introduction On August 4, 2025, the Pharmaceuticals and Medical Devices Agency (PMDA) hosted a public symposiu […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570